DHILLON PUNIT has filed 36 insider transactions across 1 company since August 2023.
Most recent transaction: a disposition of 250000 shares of Skye Bioscience, Inc. ($SKYE) on March 31, 2026.
Activity breakdown: 2 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | D | Stock Option (Right to Buy) | 250000 | $0.00 | 0.0000 | 39,665,927 | 100.00% | 0.63% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | D | Stock Option (Right to Buy) | 21586 | $0.00 | 0.0000 | 39,665,927 | 100.00% | 0.05% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | A | Stock Option (Right to Buy) | 21586 | $0.00 | 21,586.0000 | 39,665,927 | 9999.99% | 0.05% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | D | Stock Option (Right to Buy) | 9013 | $0.00 | 0.0000 | 39,665,927 | 100.00% | 0.02% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | A | Stock Option (Right to Buy) | 9013 | $0.00 | 9,013.0000 | 39,665,927 | 9999.99% | 0.02% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | D | Stock Option (Right to Buy) | 125000 | $0.00 | 0.0000 | 39,665,927 | 100.00% | 0.32% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 39,665,927 | 9999.99% | 0.32% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | D | Stock Option (Right to Buy) | 650000 | $0.00 | 0.0000 | 39,665,927 | 100.00% | 1.64% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | A | Stock Option (Right to Buy) | 650000 | $0.00 | 650,000.0000 | 39,665,927 | 9999.99% | 1.64% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | D | Stock Option (Right to Buy) | 12360 | $0.00 | 0.0000 | 39,665,927 | 100.00% | 0.03% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | A | Stock Option (Right to Buy) | 12360 | $0.00 | 12,360.0000 | 39,665,927 | 9999.99% | 0.03% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 39,665,927 | 9999.99% | 0.63% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | D | Stock Option (Right to Buy) | 36000 | $0.00 | 0.0000 | 39,665,927 | 100.00% | 0.09% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | A | Stock Option (Right to Buy) | 36000 | $0.00 | 36,000.0000 | 39,665,927 | 9999.99% | 0.09% |
| Feb. 6, 2026 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | A | Stock Option (Right to Buy) | 280000 | $0.00 | 280,000.0000 | 39,665,927 | 9999.99% | 0.71% |
| Feb. 24, 2025 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 36,486,519 | 9999.99% | 0.69% |
| Nov. 15, 2024 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | S | Common Stock | 364 | $5.55 | 421,712.0000 | 38,819,387 | 0.09% | 0.00% |
| Nov. 18, 2024 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | S | Common Stock | 82546 | $4.99 | 339,166.0000 | 38,819,387 | 19.57% | 0.21% |
| Oct. 28, 2024 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | A | Stock Option (Right to Buy) | 650000 | $0.00 | 650,000.0000 | 38,819,387 | 9999.99% | 1.67% |
| Aug. 26, 2024 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | J | Common Stock | 15727 | $0.00 | 422,076.0000 | 7,006,038 | 3.87% | 0.22% |
| Feb. 29, 2024 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 7,006,038 | 9999.99% | 1.78% |
| Feb. 29, 2024 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | A | Common Stock | 100000 | $0.00 | 397,006.0000 | 7,006,038 | 33.67% | 1.43% |
| Feb. 29, 2024 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 7,006,038 | 9999.99% | 1.78% |
| Feb. 29, 2024 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | A | Common Stock | 100000 | $0.00 | 397,006.0000 | 7,006,038 | 33.67% | 1.43% |
| Nov. 6, 2023 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | A | Common Stock | 194270 | $0.00 | 297,006.0000 | 0 | 189.10% | 0.00% |
| Nov. 6, 2023 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | A | Stock Option (Right to Buy) | 21586 | $0.00 | 30,599.0000 | 0 | 239.50% | 0.00% |
| Aug. 23, 2023 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | L | Common Stock | 9000 | $0.01 | 27,028,678.0000 | 0 | 0.03% | 0.00% |
| Aug. 25, 2023 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | A | Common Stock | 20277414 | $0.00 | 27,019,678.0000 | 0 | 300.75% | 0.00% |
| Aug. 25, 2023 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | A | Stock Option (Right to Buy) | 2253046 | $0.00 | 2,253,046.0000 | 0 | 9999.99% | 0.00% |
| Aug. 29, 2023 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | P | Common Stock | 881000 | $0.02 | 28,019,678.0000 | 0 | 3.25% | 0.00% |
| Aug. 28, 2023 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | L | Common Stock | 110000 | $0.02 | 27,138,678.0000 | 0 | 0.41% | 0.00% |
| Aug. 25, 2023 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | A | Stock Option (Right to Buy) | 2253046 | $0.00 | 2,253,046.0000 | 0 | 9999.99% | 0.00% |
| Aug. 29, 2023 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | P | Common Stock | 881000 | $0.02 | 41,554,828.0000 | 0 | 2.17% | 0.00% |
| Aug. 28, 2023 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | L | Common Stock | 110000 | $0.02 | 40,673,828.0000 | 0 | 0.27% | 0.00% |
| Aug. 23, 2023 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | L | Common Stock | 9000 | $0.01 | 40,563,828.0000 | 0 | 0.02% | 0.00% |
| Aug. 25, 2023 | Skye Bioscience, Inc. | $SKYE | DHILLON PUNIT | Chief Executive Officer | A | Common Stock | 20277414 | $0.00 | 40,554,828.0000 | 0 | 100.00% | 0.00% |